← Evidence map

TrialNature2022

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.

Daniel Zingg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

67 papers cite itlatest 60 shown

2022
…
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35948633